Recombinant Cynomolgus Monkey Fas/TNFRSF6/CD95 Fc, CF
Recombinant Cynomolgus Monkey Fas/TNFRSF6/CD95 Fc, CF Summary
Product Specifications
Cynomolgus Monkey Fas/TNFRSF6/CD95 (Gln26-Asp173) Accession # Q9TSN4.1 | IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus | |
Analysis
Product Datasheets
10755-FS
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
10755-FS
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 500 μg/mL in PBS. |
Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Scientific Data
Recombinant Cynomolgus Monkey Fas/TNFRSF6/CD95 Fc Chimera (Catalog # 10755-FS), inhibits Fas Ligand-induced apoptosis of Jurkat human acute T cell leukemia cells. The ED50 for this effect is 40.0-240 ng/mL.
2 μg/lane of Recombinant Cynomolgus Monkey Fas/TNFRSF6/CD95 Fc Chimera (Catalog # 10755-FS) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 55-70 kDa and 110-140 kDa, respectively.
Background: Fas/TNFRSF6/CD95
Fas (fibroblast associated; also known as APO-1 or CD95) is a member of the death receptor subfamily of the TNF receptor superfamily and is designated TNFRSF6 (1-3). The human Fas precursor is 335 amino acids (aa) in length, and contains a 25 aa signal peptide, a 148 aa extracellular domain (ECD), a 17 aa transmembrane sequence, and a 145 aa cytoplasmic region. The ECD possesses three cysteine-rich TNFR repeats, while the cytoplasmic region contains one death domain (DD) that is required for the transduction of apoptotic signals (4). Cynomolgus monkey Fas ECD shares 91% aa sequence identity with human Fas ECD. A human Fas isoform of 314 aa that lacks the transmembrane sequence is secreted by resting lymphocytes, while isoforms of 149, 132, 103 and 86 aa that also lack the DD and show substitutions for parts of the TNFR repeats are less prominently expressed (4-6). All five isoforms block the extrinsic apoptosis pathway induced by Fas ligand binding. Fas ligand (FasL; also TNFSF6) is a type II transmembrane protein that belongs to the TNF family and is expressed on activated T-cells, NK cells, and cells found in immune privileged sites. Alternatively, FasL is also shed as a soluble form (2, 6). Engagement of FasL induces oligomerization of preformed Fas trimers (1, 2). This activated receptor complex recruits the adaptor molecule FADD to form the Death-Inducing Signaling Complex (DISC). Upon activation, caspases in the DISC initiate the apoptotic signaling cascade (7). Fas is prominent in epithelial cells, hepatocytes, activated mature lymphocytes, virus-transformed lymphocytes and tumor cells. It is an essential mediator in the activation-induced death of T lymphocytes that terminates the immune reaction (1, 2, 8). In immune-privileged tissues, infiltrating Fas-bearing lymphocytes and inflammatory cells are killed by FasL engagement (9). Both humans and mice with genetic defects in Fas accumulate abnormal lymphocytes and develop systemic autoimmunity (1-3). The Fas pathway also appears to intersect with the BIM (mitochondrial/intrinsic) apoptosis pathway (1).
- Bouillet, P. and L.A. O’Reilly (2009) Nat. Rev. Immunol. 9:514.
- Strasser, A. et al. (2009) Immunity 30:180.
- Ashkenazi, A. and V. Dixit (1999) Curr. Opin. Cell Biol. 11:255.
- SwissProt Accession # P25445.
- Liu, C. et al. (1995) Biochem. J. 310:957.
- Papoff, G. et al. (1996) J. Immunol. 156:4622.
- Thorburn, A. (2003) Cellular Signaling 16:139.
- Barreiro, R. et al. (2004) J. Immunol. 173:1519.
- Ferguson, T.A. and T.S Griffith (2006) Immunol. Rev. 213:228.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Cynomolgus Monkey Fas/TNFRSF6/CD95 Fc, CF
There are currently no reviews for this product. Be the first to review Recombinant Cynomolgus Monkey Fas/TNFRSF6/CD95 Fc, CF and earn rewards!
Have you used Recombinant Cynomolgus Monkey Fas/TNFRSF6/CD95 Fc, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image